Nicotine has recently been promoted by some wellness influencers as a substance that can enhance cognitive function, improve focus, and protect against age-related cognitive decline. Advocates, often aligned with the Make America Healthy Again movement, have spread claims that nicotine—distinct from its traditional association with tobacco use—can serve as a natural cognitive enhancer and mood regulator when used in noncombustible forms such as nicotine pouches or in combination with caffeine and nootropics.

However, medical experts caution that the scientific evidence does not support these broad assertions. Nicotine is the primary addictive ingredient in tobacco products, including cigarettes, vapes, cigars, and smokeless tobacco. The greatest health risks stem from the combustion of tobacco, which produces numerous toxic chemicals linked to cancer, cardiovascular disease, and respiratory illnesses. Nevertheless, nicotine itself also poses risks to the brain and body.

Nicotine activates the sympathetic nervous system, increasing heart rate and blood pressure, while potentially disrupting sleep patterns. Exposure during critical developmental periods, such as prenatal stages and adolescence, is particularly concerning due to its association with impaired fetal growth and lasting impacts on neural systems related to attention, learning, and reward processing. Repeated nicotine exposure also leads to dependence by altering brain reward pathways.

While nicotine engages receptors related to acetylcholine—a neurotransmitter involved in attention and memory—it does so with longer-lasting effects that can alter brain activity and promote addiction. Some studies have found that nicotine may temporarily improve attention, vigilance, and working memory, particularly among individuals with mild cognitive impairment. However, evidence that nicotine enhances cognition in healthy users is inconsistent, with some findings suggesting potential impairments in higher-performing individuals.

Experts note that difficulty concentrating and irritability during nicotine withdrawal can complicate interpretations of cognitive benefits. Users often report improved focus upon resuming nicotine, but this may reflect relief from withdrawal symptoms rather than true cognitive enhancement.

Nicotine’s impact on mood and stress management is similarly complex. While stimulation of brain reward pathways can create a temporary sense of well-being, long-term use may disrupt the body's stress response, potentially worsening anxiety and stress over time. Research indicates that quitting nicotine typically leads to improvements in mood, reduced anxiety, and overall better mental health.

More ambitious wellness claims include suggestions that nicotine might protect against neurodegenerative diseases such as Alzheimer’s and Parkinson’s. These assertions are based largely on laboratory and animal research showing nicotine’s influence on neural pathways and cellular processes related to oxidative stress and inflammation. Nonetheless, human studies have yet to demonstrate a protective or disease-modifying effect of nicotine on dementia or cognitive decline.

Nicotine replacement therapies approved by regulatory agencies remain important tools for helping individuals overcome dependence but should not be conflated with unproven claims of cognitive or longevity benefits. Medical professionals urge caution in embracing nicotine as a wellness supplement given the lack of robust evidence and the substance’s addictive potential and health risks.